Technical Analysis for ATAI - ATAI Life Sciences N.V.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 2.01 | -1.95% | -0.04 |
ATAI closed down 1.95 percent on Wednesday, May 8, 2024, on 20 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Flat | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
50 DMA Support | Bullish | 0.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Earnings Movers | Other | 0.00% | |
20 DMA Support | Bullish | -1.95% | |
Earnings Movers | Other | -1.95% | |
Wide Bands | Range Expansion | -1.95% | |
Crossed Above 20 DMA | Bullish | -5.19% | |
MACD Bullish Centerline Cross | Bullish | -5.19% |
Alert | Time |
---|---|
10 DMA Resistance | about 19 hours ago |
20 DMA Resistance | about 20 hours ago |
Gap Down Closed | about 21 hours ago |
Reversed from Down | about 21 hours ago |
20 DMA Support | about 21 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai was founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, as well as the emergence of therapies that previously may have been overlooked or underused, including psychedelic compounds and digital therapeutics. atai is headquartered in Berlin, with offices in New York and London.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Medication Disability Mental Health Psychiatry Mental Disorder Positive Psychology Mental Health Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Medication Disability Mental Health Psychiatry Mental Disorder Positive Psychology Mental Health Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.85 |
52 Week Low | 1.025 |
Average Volume | 1,715,388 |
200-Day Moving Average | 1.63 |
50-Day Moving Average | 2.00 |
20-Day Moving Average | 2.03 |
10-Day Moving Average | 2.01 |
Average True Range | 0.17 |
RSI (14) | 49.24 |
ADX | 21.34 |
+DI | 24.71 |
-DI | 15.76 |
Chandelier Exit (Long, 3 ATRs) | 2.08 |
Chandelier Exit (Short, 3 ATRs) | 2.30 |
Upper Bollinger Bands | 2.33 |
Lower Bollinger Band | 1.73 |
Percent B (%b) | 0.47 |
BandWidth | 29.85 |
MACD Line | 0.00 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0026 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.14 | ||||
Resistance 3 (R3) | 2.16 | 2.12 | 2.12 | ||
Resistance 2 (R2) | 2.12 | 2.09 | 2.12 | 2.11 | |
Resistance 1 (R1) | 2.07 | 2.07 | 2.05 | 2.05 | 2.11 |
Pivot Point | 2.03 | 2.03 | 2.02 | 2.03 | 2.03 |
Support 1 (S1) | 1.98 | 2.00 | 1.96 | 1.97 | 1.91 |
Support 2 (S2) | 1.94 | 1.98 | 1.94 | 1.91 | |
Support 3 (S3) | 1.89 | 1.94 | 1.90 | ||
Support 4 (S4) | 1.88 |